Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.8600
-0.0100 (-1.15%)
At close: May 13, 2025, 4:00 PM
0.9224
+0.0624 (7.26%)
Pre-market: May 14, 2025, 7:11 AM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $5.20 million as of May 14, 2025. Its market cap has decreased by -31.13% in one year.
Market Cap
5.20M
Enterprise Value
-1.72M
1-Year Change
-31.13%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $5.20M, a decrease of -92.03%. That is a compound annual growth rate of -49.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 5.27M | 31.99% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.88B |
| Johnson & Johnson | 370.90B |
| UnitedHealth Group | 343.99B |
| AbbVie | 337.56B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.27B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |